(Q48115258)

8 February 2018

title

7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum. (English)

1 reference

8 February 2018

1 reference

J E Royland

1

1 reference

8 February 2018

K Delfani

2

1 reference

8 February 2018

J W Langston

3

1 reference

8 February 2018

A M Janson

4

1 reference

8 February 2018

D A Di Monte

5

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

8 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

8 February 2018

volume

839

1 reference

8 February 2018

page(s)

41-48

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Nitric oxide synthase: Irreversible inhibition by L-NG-Nitroarginine in brain in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

The efficiency of systematic sampling in stereology and its prediction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Targeted disruption of the neuronal nitric oxide synthase gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Continuous measurement of adenosine triphosphate with firefly luciferase luminescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Inhibition of mitochondrial electron transport by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901689-3

10.1016/S0006-8993(99)01689-3

7 January 2021

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10482797

1 reference

8 February 2018